Resistin effects on pancreatic cancer progression and chemoresistance are mediated through its receptors CAP1 and TLR4

Here, there and everywhere: Resistin-like molecules in infection, inflammation, and metabolic disorders

(2018) Gabrielle M. Pine et al.   CYTOKINE

Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer

(2018) Claire Vennin et al.   GASTROENTEROLOGY

Association of RETN and CAP1 SNPs, Expression and Serum Resistin Levels with Breast Cancer in Mexican Women

(2018) Alejandrina Muñoz-Palomeque et al.   Genetic Testing and Molecular Biomarkers

Resistin inhibits neuronal autophagy through Toll-like receptor 4

(2018) Jie Miao et al.   JOURNAL OF ENDOCRINOLOGY

Association of adenylate cyclase-associated protein 1 with coronary artery disease

(2017) Jelena Munjas et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression

(2017) Jianan Pang et al.   HAEMATOLOGICA

The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer

(2017) Angela M. Krebs et al.   NATURE CELL BIOLOGY

Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties

(2017) C-H Wang et al.   ONCOGENE

Resistin promotes CCL4 expression through toll-like receptor-4 and activation of the p38-MAPK and NF-κB signaling pathways: implications for intervertebral disc degeneration

(2017) Z. Li et al.   OSTEOARTHRITIS AND CARTILAGE

Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancer

(2017) Jukka Kallio et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression

(2017) Jianan Pang et al.   HAEMATOLOGICA

Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement

(2016) Rashmi Bharti et al.   CANCER LETTERS

Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling

(2016) Yunliang Sun et al.   EXPERIMENTAL CELL RESEARCH

Resistin Induces Hypertension and Insulin Resistance in Mice via a TLR4-Dependent Pathway

(2016) Yun Jiang et al.   Scientific Reports

Resistin: Insulin resistance to malignancy

(2015) Pilar Codoñer-Franch et al.   CLINICA CHIMICA ACTA

Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells

(2015) Chun-Hao Tsai et al.   Oncotarget

Adenylyl Cyclase-Associated Protein 1 Is a Receptor for Human Resistin and Mediates Inflammatory Actions of Human Monocytes

(2014) Sahmin Lee et al.   Cell Metabolism

Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf–Hirschhorn syndrome candidate 1/Twist pathway

(2013) Chih-Hsin Kuo et al.   CARCINOGENESIS

Role of adipocytokines and its correlation with endocrine pancreatic function in patients with pancreatic cancer

(2013) Anita Gąsiorowska et al.   PANCREATOLOGY

Expression of the adipocytokine resistin and its association with the clinicopathological features and prognosis of pancreatic ductal adenocarcinoma

(2012) CHONG-YI JIANG et al.   Oncology Letters

Relationship of resistin levels with endometrial cancer risk

(2011) M. HLAVNA et al.   NEOPLASMA

Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer

(2009) Takako Eguchi Nakajima et al.   JOURNAL OF GASTROENTEROLOGY

Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility

(2009) Ken Yamazaki et al.   LABORATORY INVESTIGATION

Resistin in Human Colorectal Cancer: Increased Expression Independently of Resistin Promoter −420C > G genotype

(2008) Dick Wågsäter et al.   CANCER INVESTIGATION

The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC)

(2008) Eleni M. Karapanagiotou et al.   LUNG CANCER